HomeIMNM • NASDAQ
Immunome Inc
add
In the news
Defense World
2 days ago
BNP Paribas Financial Markets Invests $70,000 in Immunome, Inc. (NASDAQ:IMNM)
0.19%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.93M | 184.35% |
Operating expense | 10.69M | 78.02% |
Net income | -41.64M | 67.84% |
Net profit margin | -1.42K | 88.69% |
Earnings per share | -0.52 | 79.28% |
EBITDA | -44.03M | -118.08% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 317.32M | 2.46% |
Total assets | 342.69M | 7.17% |
Total liabilities | 35.57M | 4.05% |
Total equity | 307.13M | — |
Shares outstanding | 87.01M | — |
Price to book | 2.56 | — |
Return on assets | -38.29% | — |
Return on capital | -44.82% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -41.64M | 67.84% |
Cash from operations | -53.06M | -374.98% |
Cash from investing | 5.09M | 113.67% |
Cash from financing | 162.23M | -26.07% |
Net change in cash | 114.26M | -33.20% |
Free cash flow | -56.60M | -58.30% |
Previous close
$9.02
Day range
$8.76 - $9.34
Year range
$5.15 - $16.81
Market cap
803.99M USD
Avg Volume
974.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Headquarters
Website
Employees
131
